Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo
Open Access
- 10 June 2010
- journal article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 10 (1), 276-9
- https://doi.org/10.1186/1471-2407-10-276
Abstract
Epigallocatechin-3-gallate (EGCG), one of the major catechins in green tea, is a potential chemopreventive agent for various cancers. The aim of this study was to examine the effect of EGCG on the expression of heat shock proteins (HSPs) and tumor suppression. Cell colony formation was evaluated by a soft agar assay. Transcriptional activity of HSP70 and HSP90 was determined by luciferase reporter assay. An EGCG-HSPs complex was prepared using EGCG attached to the cyanogen bromide (CNBr)-activated Sepharose 4B. In vivo effect of EGCG on tumor growth was examined in a xenograft model. Treatment with EGCG decreased cell proliferation and colony formation of MCF-7 human breast cancer cells. EGCG specifically inhibited the expression of HSP70 and HSP90 by inhibiting the promoter activity of HSP70 and HSP90. Pretreatment with EGCG increased the stress sensitivity of MCF-7 cells upon heat shock (44°C for 1 h) or oxidative stress (H2O2, 500 μM for 24 h). Moreover, treatment with EGCG (10 mg/kg) in a xenograft model resulted in delayed tumor incidence and reduced tumor size, as well as the inhibition of HSP70 and HSP90 expression. Overall, these findings demonstrate that HSP70 and HSP90 are potent molecular targets of EGCG and suggest EGCG as a drug candidate for the treatment of human cancer.Keywords
This publication has 41 references indexed in Scilit:
- (−)-Epigallocatechin-3-gallate Inhibits Hsp90 Function by Impairing Hsp90 Association with Cochaperones in Pancreatic Cancer Cell Line Mia Paca-2Molecular Pharmaceutics, 2009
- Heterotrimerization of Heat-Shock Factors 1 and 2 Provides a Transcriptional Switch in Response to Distinct StimuliMolecular Biology of the Cell, 2009
- TAT‐Hsp40 inhibits oxidative stress‐mediated cytotoxicity via the inhibition of Hsp70 ubiquitinationFEBS Letters, 2008
- (−)-Epigallocatechin-3-gallate downregulates estrogen receptor alpha function in MCF-7 breast carcinoma cellsCancer Detection Prevention, 2007
- Induction of heat shock proteins by heregulin β1 leads to protection from apoptosis and anchorage-independent growthOncogene, 2005
- Epigallocatechin-3-gallate Inhibits Epidermal Growth Factor Receptor Signaling PathwayJournal of Biological Chemistry, 2004
- Treatment of epigallocatechin‐3‐gallate inhibits matrix metalloproteinases‐2 and ‐9 via inhibition of activation of mitogen‐activated protein kinases, c‐jun and NF‐κB in human prostate carcinoma DU‐145 cellsThe Prostate, 2003
- Protection against induction of mouse skin papillomas with low and high risk of conversion to malignancy by green tea polyphenolsCarcinogenesis: Integrative Cancer Research, 1997
- Effect of (-)-epigallocatechin gallate on leukemic blast cells from patients with acute myeloblastic leukemiaLife Sciences, 1996
- THE HEAT-SHOCK PROTEINSAnnual Review of Genetics, 1988